Hypoperfusion, Hemodynamic Control Domains and Neurovascular Dysregulation in AD brain pathology
AD 脑病理学中的低灌注、血流动力学控制域和神经血管失调
基本信息
- 批准号:10654258
- 负责人:
- 金额:$ 50.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAnimal Disease ModelsAnimalsBehavioralBlood VesselsBlood capillariesBlood flowBrainBrain PathologyCell WallCerebrovascular CirculationCerebrumClinicalCyclophilin ADegenerative DisorderDementiaDiseaseDisease ProgressionElementsEtiologyFutureG-Protein-Coupled ReceptorsGenderGenesGeneticGenotypeGlucoseGlutamatesGoalsHippocampusHumanHyperemiaHypoxiaIn VitroInterventionLinkLongevityMemoryMetabolicMetabolismModelingMusNeocortexNerve DegenerationNeuronsPathologicPathway interactionsPericytesPhenotypePhosphatidylinositol 4,5-DiphosphatePhysiologicalPhysiologyPopulationPotassium ChannelPremature aging syndromeRegulationRisk FactorsSenile PlaquesSignal TransductionSliceStereotypingStrokeSynapsesSyndromeTimeTissuesTrainingVasodilationage effectage relatedaging brainanalogapolipoprotein E-4brain metabolismcerebrovascularcholinergicconstrictiondesigner receptors exclusively activated by designer drugsdisease phenotypeexperienceextracellulargenetic approachhemodynamicshypoperfusionimprovedin vivometabolic ratemetabolomicsmouse modelneocorticalneuralneurotransmissionneurovascularneurovascular couplingnovel strategiespatch clamppre-clinicalprematurepreventprogressive neurodegenerationresponsespreading depressiontau-1translational modeltreatment strategy
项目摘要
Alzheimer’s Disease [AD] is a progressive degenerative disorder of unclear etiology and disease-modifying
treatments remain elusive. Abnormal neurovascular regulation can lead to reduced substrate supply to brain,
including capillary and small vessel pericyte regulation with neuronal activity, conduction from small vessels to
larger scale vessels, and hemodynamic responses to neuronal activity. Neurovascular regulation mechanisms
in the context of the aging brain can be differentiated from the premature aging and progressive
neurodegeneration associated with AD and dementia syndrome. Early pathological neurovascular and
metabolic alterations can reduce substrate delivery to the AD brain. Though brain metabolism is altered during
aging, AD demonstrates more severe and premature metabolic insufficiency in comparison to age-matched
controls, attributable to neurovascular dysregulation at multiple levels.
We will analyze mechanisms of neurovascular regulation occurring in age-matched control genotypes (both
wildtype C57Bl/6 and mNOS2-/-) compared to the progressive degeneration noted in the CVN-AD animal
model of Alzheimer’s disease (APPSwDI +/+ mNos2−/−). This unique mouse model closely mirrors human
phenotypic changes, particularly amyloid plaques around blood vessels, phosphorylated tau, and severe
neurodegeneration. Our hypothesis is that degeneration, as noted in both human AD and the relevant CVN-AD
animal model, is worsened by premature aging changes in substrate supply at the capillary, pericyte,
conduction, and hemodynamic levels. Metabolic insufficiency can arise particularly from abnormal
neurovascular coupling and conduction from small to larger vessels, blunting the hemodynamic response to
dynamic neuronal activity. The CVN-AD model mirrors human AD phenotypes with a predictable time course of
behavioral, vascular and circuit degeneration in relation to aging changes hence provides an appropriate pre-
clinical, translational model for analyzing these concepts. We will study novel approaches to evaluating
mechanisms of neurovascular regulation including chemogenetic approaches at the pericyte, mural wall cell
level, assessing activity and conduction to larger capacity cerebral vessels, neurovascular coupling and
hemodynamic responses, to understand dynamic mechanisms of hypoperfusion at critical times of substrate
need, in both hippocampus and neocortex as a function of genotype, gender, and age.
阿尔茨海默病(Alzheimer's Disease,AD)是一种病因不明的进行性退行性疾病,
治疗仍然难以捉摸。异常的神经血管调节可导致对脑的底物供应减少,
包括毛细血管和小血管周细胞的调节与神经元的活动,从小血管传导到
更大规模的血管,以及对神经元活动的血液动力学反应。神经血管调节机制
在大脑老化的背景下,可以从过早衰老和渐进性衰老中区分出来。
与AD和痴呆综合征相关的神经变性。早期病理性神经血管和
代谢改变可减少底物递送至AD脑。虽然大脑的新陈代谢在
与年龄匹配的相比,AD表现出更严重和过早的代谢功能不全
对照组,归因于多个水平的神经血管失调。
我们将分析发生在年龄匹配的对照基因型中的神经血管调节机制(两者都是)。
野生型C57 B1/6和mNOS 2-/-)与在CVN-AD动物中观察到的进行性变性相比
阿尔茨海默病模型(APPSwDI +/+ mNos 2 −/−)。这种独特的小鼠模型非常接近人类
表型变化,特别是血管周围的淀粉样斑块,磷酸化tau蛋白,以及严重的
神经变性我们的假设是,如在人类AD和相关的CVN-AD中所注意到的,
动物模型,由于毛细血管,周细胞,
传导和血液动力学水平。代谢功能不全特别是由异常
从小血管到大血管的神经血管耦合和传导,使血液动力学反应减弱,
动态神经元活动CVN-AD模型反映了人类AD表型,具有可预测的时间进程,
行为、血管和回路退化与年龄变化的关系,因此提供了一个适当的预
临床的、转化的模型来分析这些概念。我们将研究新的方法来评估
神经血管调节的机制,包括周细胞、壁细胞的化学发生途径
水平,评估活动和传导到更大容量的脑血管,神经血管耦合和
血流动力学反应,以了解在基质的关键时刻低灌注的动力学机制
需要,在海马和新皮层作为基因型,性别和年龄的函数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS Alan TURNER其他文献
DENNIS Alan TURNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS Alan TURNER', 18)}}的其他基金
An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease
帕金森病个性化、适应性深部脑刺激的综合生物标志物方法
- 批准号:
10571952 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Central and Peripheral Neuromodulation during Activity to Synergistically Augment Stroke Recovery
活动期间的中枢和外周神经调节可协同增强中风恢复
- 批准号:
10775774 - 财政年份:2022
- 资助金额:
$ 50.14万 - 项目类别:
Extracranial Brain Stimulation Reduces Metabolic Insufficiency Through Enhanced Cerebral Blood Flow in CVN-AD Alzheimer's Model
颅外脑刺激通过增强 CVN-AD 阿尔茨海默病模型中的脑血流量来减少代谢不足
- 批准号:
10338855 - 财政年份:2022
- 资助金额:
$ 50.14万 - 项目类别:
Extracranial Brain Stimulation Reduces Metabolic Insufficiency Through Enhanced Cerebral Blood Flow in CVN-AD Alzheimer's Model
颅外脑刺激通过增强 CVN-AD 阿尔茨海默病模型中的脑血流量来减少代谢不足
- 批准号:
10554248 - 财政年份:2022
- 资助金额:
$ 50.14万 - 项目类别:
Central and Peripheral Neuromodulation during Activity to Synergistically Augment Stroke Recovery
活动期间的中枢和外周神经调节可协同增强中风恢复
- 批准号:
10588544 - 财政年份:2022
- 资助金额:
$ 50.14万 - 项目类别:
Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials
基于诱发电位和自发电位的标量闭环 STN/GPi DBS
- 批准号:
9564229 - 财政年份:2017
- 资助金额:
$ 50.14万 - 项目类别:
Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials
基于诱发电位和自发电位的标量闭环 STN/GPi DBS
- 批准号:
9404120 - 财政年份:2017
- 资助金额:
$ 50.14万 - 项目类别:
Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials
基于诱发电位和自发电位的标量闭环 STN/GPi DBS
- 批准号:
10219364 - 财政年份:2017
- 资助金额:
$ 50.14万 - 项目类别:
Fornix Stimulation Enhances Neurovascular Plasticity in Alzheimer's Mouse Model
穹窿刺激增强阿尔茨海默病小鼠模型的神经血管可塑性
- 批准号:
9269882 - 财政年份:2016
- 资助金额:
$ 50.14万 - 项目类别:
Neuronal Fatigue in Aging Hippocampus during Sustained Metabolic Demand
持续代谢需求期间老化海马的神经元疲劳
- 批准号:
8097946 - 财政年份:2010
- 资助金额:
$ 50.14万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 50.14万 - 项目类别:
Operating Grants